Inpharma Weekly

, Volume 765, Issue 1, pp 15–15 | Cite as

Tamoxifen is a contender for a first-line position in estrogen receptor-positive breast cancer

Newsletter Article


Breast Cancer Estrogen Receptor Tamoxifen Alopecia Epirubicin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1990

Personalised recommendations